| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 74,0 k € | -46.5% | 138,3 k € | -16.6% | 165,8 k € | +7.3% | 154,6 k € | +12.0% | 138,1 k € | +9.3% | 126,3 k € | +183.7% | 44,5 k € | -15.7% | 52,8 k € | +72.1% | 30,7 k € | -49.4% | 60,6 k € | -58.8% | 147,1 k € | +23.4% | 119,2 k € | +34.2% | 88,9 k € | -56.2% | 202,7 k € | -19.8% | 252,8 k € | +3.8% | 243,6 k € | +63.6% | 148,9 k € | -17.7% | 180,8 k € | |
| EBITDA | 68,3 k € | -48.6% | 132,9 k € | -18.1% | 162,3 k € | +7.1% | 151,5 k € | +12.3% | 134,9 k € | +9.5% | 123,1 k € | +200.6% | 41,0 k € | -16.6% | 49,1 k € | +81.2% | 27,1 k € | -52.1% | 56,5 k € | -60.4% | 142,6 k € | +24.5% | 114,5 k € | +35.0% | 84,9 k € | -57.4% | 199,2 k € | -19.6% | 247,7 k € | +3.1% | 240,3 k € | +66.0% | 144,8 k € | -18.6% | 177,8 k € | |
| Operating profit | 38,8 k € | -60.0% | 96,9 k € | -26.8% | 132,5 k € | +11.2% | 119,2 k € | +15.0% | 103,6 k € | +17.4% | 88,3 k € | +463.9% | 15,7 k € | +29.6% | 12,1 k € | +292.4% | -6,3 k € | -126.4% | 23,8 k € | -75.5% | 97,2 k € | +42.9% | 68,0 k € | +61.5% | 42,1 k € | -72.9% | 155,2 k € | -21.9% | 198,6 k € | +7.6% | 184,5 k € | +90.1% | 97,1 k € | -26.5% | 132,1 k € | |
| Profit/loss | 105,9 k € | -31.9% | 155,5 k € | +24.1% | 125,3 k € | +34.0% | 93,5 k € | -14.3% | 109,0 k € | +41.6% | 77,0 k € | +470.6% | 13,5 k € | +115.5% | -87,0 k € | -178.7% | -31,2 k € | -186.8% | 36,0 k € | -48.2% | 69,4 k € | +30.0% | 53,4 k € | +70.5% | 31,3 k € | -72.4% | 113,3 k € | -29.6% | 160,9 k € | +3.2% | 155,9 k € | +105.0% | 76,0 k € | -10.7% | 85,1 k € | |
| Equity | 1,4 M € | +8.1% | 1,3 M € | +13.5% | 1,2 M € | +12.2% | 1,0 M € | +10.0% | 933,6 k € | +29.5% | 720,9 k € | +12.0% | 643,9 k € | +2.1% | 630,4 k € | -12.1% | 717,5 k € | -4.2% | 748,7 k € | +5.0% | 712,8 k € | +10.8% | 643,3 k € | +9.1% | 589,9 k € | -15.2% | 695,6 k € | +15.5% | 602,4 k € | +20.1% | 501,5 k € | +12.5% | 445,6 k € | +8.8% | 409,6 k € | |
| Total assets | 1,4 M € | +5.4% | 1,4 M € | +15.3% | 1,2 M € | +11.7% | 1,1 M € | +6.8% | 985,2 k € | +34.7% | 731,6 k € | +10.6% | 661,5 k € | +4.2% | 634,6 k € | -13.5% | 733,4 k € | -7.0% | 788,6 k € | -5.1% | 830,8 k € | +11.4% | 746,0 k € | +7.7% | 692,6 k € | -7.4% | 748,2 k € | +4.1% | 718,9 k € | +5.8% | 679,5 k € | +9.3% | 621,6 k € | +19.5% | 520,0 k € | |
| Cash | 7,9 k € | -91.0% | 87,5 k € | +145.3% | 35,7 k € | -40.5% | 60,0 k € | +126.9% | 26,4 k € | -30.4% | 38,0 k € | -3.6% | 39,4 k € | +60.2% | 24,6 k € | +37.1% | 17,9 k € | -92.5% | 239,8 k € | -34.1% | 363,8 k € | +48.7% | 244,7 k € | +18.7% | 206,3 k € | +57.2% | 131,2 k € | +8.5% | 120,9 k € | +8.7% | 111,2 k € | +76.4% | 63,0 k € | +281.4% | 16,5 k € | |
| Debts | 8,6 k € | -79.0% | 41,1 k € | +135.8% | 17,4 k € | +38.4% | 12,6 k € | -72.4% | 45,5 k € | +325.9% | 10,7 k € | -39.0% | 17,5 k € | +318.1% | 4,2 k € | -72.8% | 15,4 k € | -61.3% | 39,9 k € | -41.4% | 68,0 k € | -33.7% | 102,6 k € | -0.0% | 102,6 k € | +95.4% | 52,5 k € | -54.9% | 116,5 k € | -34.6% | 178,1 k € | +53.5% | 116,0 k € | +5.0% | 110,5 k € | |
Private limited company · Temse · incorporated on 09/06/1991
Private limited company profitable and well capitalised. Cash position declining (-91.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
WELLEMAN, huisartsengeneeskunde is a Private limited company incorporated in 1991. Its main activity is: General medical practice activities. Its registered office is in Temse.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette